European Life Science Tools and Reagents Market: Strategies for Growth and Innovation
November 26, 2024 12:34 ET
|
BCC Research LLC
Boston, Nov. 26, 2024 (GLOBE NEWSWIRE) -- “According to the latest study from Research, “European Life Science Tools and Reagents Market,” the market for COVID-19 diagnostics products was $14.7...
Integra LifeSciences Opens New Center of Innovation and Learning
May 11, 2023 16:30 ET
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, hosted a ribbon-cutting ceremony on Thursday,...
Misonix Appoints Patrick J. Beyer to Board of Directors
May 14, 2021 08:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 14, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Reports Fiscal 2021 Third Quarter Financial Results
May 06, 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6
April 20, 2021 08:15 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., April 20, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Participate at Upcoming Investor Conferences
February 11, 2021 10:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix Reports Fiscal 2021 Second Quarter Financial Results
February 04, 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
January 21, 2021 10:30 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Report Fiscal 2020 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 3
August 06, 2020 08:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Misonix to Present at the 17th Annual Craig Hallum Institutional Investor Conference On May 27
May 22, 2020 13:00 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...